Data Foundry

Drug recalls 2025

Carvedilol Tablets USP 6 — Class II drug recall D-0449-2025

Ongoing recall by Glenmark Pharmaceuticals Inc., USA, reported 2025-06-04, distributed nationwide. CGMP Deviations; presence 'N-Nitroso Carvedilol I' Impurity above the recommended acceptable intake limit

Recall numberD-0449-2025
Product typeDrug
ClassificationClass II
StatusOngoing
Voluntary or mandatedVoluntary
Recalling firmGlenmark Pharmaceuticals Inc., USA, Mahwah, NJ, United States
Recall initiated2025-02-28
Classified2025-05-28
Reported by FDA2025-06-04
DistributedNationwide (US)
Reason classescgmp, specification failure
NDC68462-0162, 68462-0162-01, 68462-0162-05, 68462-0162-10, 68462-0162-18, 68462-0162-60, 68462-0163, 68462-0163-01, 68462-0163-05, 68462-0163-10, 68462-0163-18, 68462-0163-60, 68462-0164, 68462-0164-01, 68462-0164-05, 68462-0164-10, 68462-0164-18, 68462-0164-60, 68462-0165, 68462-0165-01, 68462-0165-05, 68462-0165-10, 68462-0165-18, 68462-0165-60
Lot numbers19231164, 19231174, 19231199, 19231448, 19231517, 19231527, 19231566, 19231568, 19231595, 19231618, 19231634, 19231638, 19232043, 19232051, 19232064, 19232322, 19232324, 19232365, 19232380, 19232389, 19232736, 19232743, 19232746, 19232756, 19232757, 19233369, 19233371, 19233405, 19233416, 19234162, 19234165, 19234183, 19234192, 19234204, 19234223, 19234242, 19234243, 19234263, 19234743, 19234774 and 20 more

Product

Carvedilol Tablets USP 6.25 mg, a.)100-count bottle (NDC 68462-163-01), b.) 500-count bottle (NDC 68462-163-05) Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd., Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430.

Reason for recall

CGMP Deviations; presence 'N-Nitroso Carvedilol I' Impurity above the recommended acceptable intake limit

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0449-2025. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.